TradingMarkets’ 10 Stocks You Need To Know About Today
AIG said it will delay its annual filing for a second time, citing an
“extensive review” of its records.
According to Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating), a federal court granted an injunction
against Teva Pharmaceuticals
(
TEVA |
Quote |
Chart |
News |
PowerRating), preventing it from marketing a
generic version of Accupril–a Pfizer drug.
Tetra Tech
(
TTEK |
Quote |
Chart |
News |
PowerRating) said it would lose $50 million in Q2. The stock
is trading down pre-open.
Micron Technology
(
MU |
Quote |
Chart |
News |
PowerRating) reversed a year ago loss, reporting a $118
million profit. Shares are up pre-open.
Bristol Myers
(
BMY |
Quote |
Chart |
News |
PowerRating) and Corgentech
(
CGTK |
Quote |
Chart |
News |
PowerRating) said their
experimental coronary bypass product, E2F Decoy, did not meet goals in late
stage clinical trials. BMY is terminating its collaboration with CGTK.
Separately, BMY won approval for its hepatitis B drug, Baraclude.
Best Buy will delay its Q4 earnings report.
Michael’s Stores
(
MIK |
Quote |
Chart |
News |
PowerRating) raised its Q1 sales and earnings forecast.
Merrill Lynch raised AMR to a ‘buy.’